The role of oncogenic human papillomaviruses in tonsillar squamous cell carcinomas with functional inactivation of the retinoblastoma protein;Onkogene humane papillomaviren. Schlusselrolle bei plattenepithelkarzinomen der tonsillen mit defekt im retinoblastomprotein

HNO

Volumn 47, Issue 9, 1999, Pages 796-803

  Helbig, M ^a   Andl, T ^a   Kahn, T ^a   Klein Kuhne W ^a   Conradt, C ^a   Dietz, A ^a   Bosch, F X ^a  

^a NONE

Author keywords

Oncogenic human papillomavirus; Prognosis; Retinoblastoma protein; Tonsillar squamous cell carcinomas

Indexed keywords

RETINOBLASTOMA PROTEIN; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN;

ARTICLE; CANCER INCIDENCE; FEMALE; GENE INACTIVATION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; SQUAMOUS CELL CARCINOMA; TONSIL CARCINOMA; TUMOR DIFFERENTIATION; WART VIRUS; CANCER STAGING; GENE EXPRESSION REGULATION; GENETICS; PAPILLOMA VIRUS; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; TONSIL; TONSIL TUMOR; VIRUS INFECTION;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; RETINOBLASTOMA PROTEIN; TONSIL; TONSILLAR NEOPLASMS;

EID: 0032589492     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001060050462     Document Type: Article

References (21)

1. Aas T, Borrensen AL, Geisler S et al. (1996) Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients. Nature Med 2:811-814
2. Almasan A, Yin Y, Kelly RE et al. (1995) Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis. Proc Natl Acad Sci USA 92:5436-5440
3. Bates S, Parry D, Bonetta L, Voudsen K, Dickson C, Peters G (1994) Absence of cyclin D1/cdk complexes in cells lacking functional retinoblastoma protein. Oncogene 9:1633-1640
4. Butz K, Shahabeddin L, Geisen C, Spitkovsky D, Ullmann A, Hoppe-Seyler F (1995) Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene 10:927-936
5. Cann CI, Fried MP, Rothman KJ (1985) Epidemiology of squamous cell cancer of the head and neck. Otolaryngol Clin 18:1-22
6. Cattani P, Hohaus S, Bellacosa A et al. (1998) Association between cyclin D1 (CCND1) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma. Clin Cancer Res 4:2585-2589
7. Dyson N, Howley PM, Münger K, Harlow E (1989) The human papillomavirus 16 E7 protein is able to bind to the retinoblastoma gene product. Science 243:934-937
8. Field JK (1992) Oncogenesand tumor-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer B28:67-76
9. Gyapay G, Morissette J, Vignal A et al. (1994) The 1993-1994 Genethon human genetic linkage map. Nature Genet 7:246-339
10. Haraf DJ, Nodzenski E, Brachman D et al. (1996) Human papillomavirus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res 2:755-762
11. Jones DL, Münger K (1997) Analysis of the p53-mediated G1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J Virol 71:2905-2912
12. Kahn T, Turazza E, Ojeda R et al. (1994) Integration of human papillomavirus type 6a DNA in a tonsillar carcinoma: chromosomal localization and nucleotide sequence of genomic target region. Cancer Res 54:1305-1312
13. Kelley MJ, Otterson GA, Kaye FJ et al. (1995) CDKN2 in HPV-positive and HPV-negative cervical carcinoma cell lines, Int J Cancer 63:226-230
14. Parry D, Bates S, Mann DJ, Peters G (1995) Lack of cyclin D-cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumor suppressor gene product. EMBO J 14:503-511
15. Paz IB, Cook N, Odom-Maryom T, Xie Y, Wilczynski SP (1997) Human papillomavirus (HPV) in head and neck cancer: an association of HPV16 with squamous cell carcinoma of the Waldeyer's tonsillar ring. Cancer 79:595-604
16. Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, Scheggert J, Manos MM (1990) Detection and typing of HPV in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 82:1477-1484
17. Reznikoff CA, Belair C, Savelieva E et al. (1994) Long-term genome stability and minimal genotypic and phenotypic alteration in HPV16 E7-, but not E6-, immortalized human urothelial cells. Genes Dev 8:2227-2240
18. Snijders PJ, Steenbergen RD, Top B, Scott SD, Meijer CJ, Walboomers JM (1994) Analysis of p53 status in tonsillar carcinomas associated with human papillomavirus. J Gen Virol 75:2769-2775
19. Symonds H, Krall L, Remington L, Saenz-Robles M, Jacks T , Van Dyke T (1994) p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 78:703-711
20. Van den Brule AJ, Claas EC, du Maine M et al. (1989) Use of anticontamination primers in the polymerase chain reaction for the detection of human papillomavirus genotypes in cervical scrapes and biopsies. J Med Virol 29:20-27
21. zur Hausen H (1996) Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta 1288:55-78